<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01104181</url>
  </required_header>
  <id_info>
    <org_study_id>R09-HPV-001</org_study_id>
    <nct_id>NCT01104181</nct_id>
  </id_info>
  <brief_title>Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test</brief_title>
  <official_title>Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laser Surgery Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>QIAGEN Gaithersburg, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laser Surgery Care</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV
      and whether this aids in identifying individuals are risk for anal cancer or precancerous
      lesions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">March 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HC2 can accurately test for oncogenic HPV in anal specimens</measure>
    <time_frame>in approximately 12 months</time_frame>
    <description>Determination that HC2 testing in the anal canal can be performed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of cytology with HC2</measure>
    <time_frame>in approximately 12 months</time_frame>
    <description>To determine if HC2 improves the sensitivity and specificity of anal cytology</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Anal Canal HPV Infection Diagnosis</condition>
  <condition>Anal Dysplasia Diagnosis</condition>
  <condition>Anal Cancer</condition>
  <arm_group>
    <arm_group_label>swab and brush or swab and swab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>we will determine which collection method is superior</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HC2 collection kit with a swab or brush</intervention_name>
    <description>We will sample the anal canal for cells with either a swab and swab or swab and brush to determine which is superior</description>
    <arm_group_label>swab and brush or swab and swab</arm_group_label>
    <other_name>Qiagen HC2 HPV High-Risk DNA Test</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. male or female 18 years of age or older

          2. screened for anal dysplasia, including MSM and women -

        Exclusion Criteria:

          1. subject has had a previous treatment for anal cancer.

          2. subjects that have used enemas or other foreign substances, in the anal canal or anal
             sex within 24 hours of collection.

          3. subjects that have bleeding disorders or use anticoagulation treatments. -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen E Goldstone, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mount Sinai Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laser Surgery Care, Inc.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2010</study_first_submitted>
  <study_first_submitted_qc>April 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2010</study_first_posted>
  <last_update_submitted>June 21, 2011</last_update_submitted>
  <last_update_submitted_qc>June 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Stephen E. Goldstone, M.D.</name_title>
    <organization>Laser Surgery Care</organization>
  </responsible_party>
  <keyword>Anal HPV</keyword>
  <keyword>Anal Dysplasia</keyword>
  <keyword>Ana Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anus Neoplasms</mesh_term>
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 17, 2014</submitted>
    <returned>April 18, 2014</returned>
    <submitted>September 10, 2014</submitted>
    <returned>September 17, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

